Levothyroxine shows no benefit in elderly patients with subclinical hypothyroidism, trial finds
Susan Mayor
Abstract
Susan Mayor
Abstract
Treatment with levothyroxine provides no clinical benefit in older people with subclinical hypothyroidism, a UK randomised trial published in the New England Journal of Medicine has shown.1 Subclinical hypothyroidism, defined as an elevated serum thyrotropin level and a serum free thyroxine level within the reference range, is common in older people, affecting 8-18% of over 65s. It is more common in women than men. Thyroid hormones have a wide …
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Treatment with levothyroxine provides no clinical benefit in older people with subclinical hypothyroidism, a UK randomised trial published in the New England Journal of Medicine has shown.1 Subclinical hypothyroidism, defined as an elevated serum thyrotropin level and a serum free thyroxine level within the reference range, is common in older people, affecting 8-18% of over 65s. It is more common in women than men. Thyroid hormones have a wide …
Key concepts: Levothyroxine, Subclinical infection, Medicine, Pediatrics, Hormone, Free thyroxine, Reference range, Clinical trial